Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novavax Fell by Over 4% Today

TheMotleyFool

0 0

Novavax (NASDAQ: NVAX) stumbled on Monday, with the stock declining by 4.4%. The key reason for the coronavirus vaccine developer's decline seems to be a set of company stock sales reported for top insiders earlier in the day.

Citing regulatory filings, Reuters reported that the biotech's CEO, Stanley Erck, and "three lieutenants" it did not name have sold around $46 million worth of Novavax stock since the beginning of 2020.

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Share